0001628280-15-001045.txt : 20150225
0001628280-15-001045.hdr.sgml : 20150225
20150225200950
ACCESSION NUMBER: 0001628280-15-001045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150223
FILED AS OF DATE: 20150225
DATE AS OF CHANGE: 20150225
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 15649667
4
1
wf-form4_142491298028934.xml
FORM 4
X0306
4
2015-02-23
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
SAN DIEGO
CA
92122
1
1
0
0
President, CEO & Secretary
Stock Option (Right to Buy)
19.69
2015-02-23
4
A
0
300000
0
A
2025-02-23
Common Stock
300000.0
300000
D
This option represents the right to purchase up to a total of 300,000 shares of the Issuer's common stock, par value $0.0001 per share (the "Option"). The Option will vest and become exercisable with respect to 25% of the underlying shares on the first anniversary of the date of grant, and then with respect to the remaining shares, on a quarterly basis over the next three years, subject to the recipient's continued service during that time.
/s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh
2015-02-25